Skip to main content
Caplight Logo









EpiCypher

EpiCypher

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://www.epicypher.com/

Last Round

Seed

Jul 1, 2024

Total Funding Raised

$9.11M

Company Overview

EpiCypher is a biotechnology company that develops and sells reagents, kits, and services for epigenetics and chromatin biology research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

CUT&RUNCUT&Tagdesigner nucleosomeschromatin mappingepigenetics toolsepigenomicsChIP-seq alternativelow input epigenomicsmultiomic profilingepigenetics drug discoveryFiber-seqhistone modification analysisepigenetics servicesDNA methylation analysisantibody validationspike-in controlsbioinformatics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiCypher Comparables

Compare EpiCypher with similar companies based on industry and business-model similarity.

EpiCypher comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Active Motif
85%
Epigentek Group Inc.
79%
Hologic, Inc.
78%

EpiCypher Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2024
GrantAug 18, 2022
AcceleratorOct 15, 2021
GrantMay 6, 2014

EpiCypher Investors

Notable investors and investment history

EpiCypher investors
InvestorRounds
NIH RADxGrant
BioTools InnovatorAccelerator
BroadOak Capital PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors increased 43% MoM, reaching 32.6K.

  • Oct 27, 2024

    Monthly visitors increased 37% MoM to 23.3K.

EpiCypher Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EpiCypher Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EpiCypher's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range52
Year Founded2012
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?